Doing damage in delirium: The hazards of antipsychotic treatment in elderly people

The Lancet Psychiatry

Volumn 1, Issue 4, 2014, Pages 312-315

  Inouye, Sharon K ^a,b   Marcantonio, Edward R ^a,b   Metzger, Eran D ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Hebrew Senior Life   (United States)

^c Division of Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; ZIPRASIDONE;

ADVERSE OUTCOME; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONFUSION; DELIRIUM; DYSPHAGIA; DYSTONIA; HUMAN; NOTE; PARKINSONISM; PATIENT SAFETY; PNEUMONIA; QT PROLONGATION; SEIZURE; VENOUS THROMBOEMBOLISM;

EID: 84920071096     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(14)70263-9     Document Type: Note

References (33)

1. Inouye SK, Westendorp RG, Saczynski JS Delirium in elderly people. Lancet 2014, 383:911-922.
2. Devlin JW, Al-Qadhee NS, Skrobik Y Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalised patients: a review of data from prospective, randomised studies. Best Pract Res Clin Anaesthesiol 2012, 26:289-309.
3. Khan BA, Zawahiri M, Campbell NL, et al. Delirium in hospitalized patients: implications of current evidence on clinical practice and future avenues for research-a systematic evidence review. J Hosp Med 2012, 7:580-589.
4. Rockoff JD Johnson & Johnson to pay $2.2 billion to settle U.S. probes: deal with Justice Department regards drug maker's selling of antipsychotic Risperdal. The Wall Street Journal Nov 4, 2013.
5. Hshieh TT, Fong TG, Marcantonio ER, Inouye SK Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci 2008, 63:764-772.
6. Greer N, Rossom R, Anderson P, et al. Delirium: screening, prevention, and diagnosis-a systematic review of the evidence 2011, Department of Veterans Affairs, Washington, DC.
7. Flaherty JH, Gonzales JP, Dong B Antipsychotics in the treatment of delirium in older hospitalized adults: a systematic review. J Am Geriatr Soc 2011, 59(suppl 2):269-276.
8. O'Mahony R, Murthy L, Akunne A, Young J Synopsis of the National Institute for Health and Clinical Excellence guideline for prevention of delirium. Ann Intern Med 2011, 154:746-751. the Guideline Development Group.
9. Page VJ, Ely EW, Gates S, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2013, 1:515-523.
10. Hakim SM, Othman AI, Naoum DO Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial. Anesthesiology 2012, 116:987-997.
11. Wang W, Li HL, Wang DX, et al. Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial. Crit Care Med 2012, 40:731-739.
12. Girard TD, Pandharipande PP, Carson SS, et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 2010, 38:428-437.
13. Larsen KA, Kelly SE, Stern TA, et al. Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics 2010, 51:409-418.
14. Prakanrattana U, Prapaitrakool S Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 2007, 35:714-719.
15. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005, 53:1658-1666.
16. Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA 2011, 306:1359-1369.
17. Gareri P, De Fazio P, Manfredi VG, De Sarro G Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol 2014, 34:109-123.
18. Muench J, Hamer AM Adverse effects of antipsychotic medications. Am Fam Physician 2010, 81:617-622.
19. Knol W, van Marum RJ, Jansen PA, Souverein PC, Schobben AF, Egberts AC Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc 2008, 56:661-666.
20. Wu CS, Lin CC, Chang CM, et al. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study. J Clin Psychiatry 2013, 74:918-924.
21. Ray WA, Chung CP, Murray KT, Hall K, Stein CM Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009, 360:225-235.
22. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005, 353:2335-2341.
23. Strawn JR, Keck PE, Caroff SN Neuroleptic malignant syndrome. Am J Psychiatry 2007, 164:870-876.
24. Schneider LS, Dagerman KS, Insel P Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005, 294:1934-1943.
25. Jasiak KD, Middleton EA, Camamo JM, Erstad BL, Snyder LS, Huckleberry YC Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium. J Pharm Pract 2013, 26:253-256.
26. Inouye SK, Kosar CM, Tommet D, et al. The CAM-S: development and validation of a new scoring system for delirium severity in 2 cohorts. Ann Intern Med 2014, 160:526-533.
27. Rubin FH, Neal K, Fenlon K, Hassan S, Inouye SK Sustainability and scalability of the Hospital Elder Life Program (HELP) at a community hospital. J Am Geriatr Soc 2011, 59:359-365.
28. Pitkälä KH, Laurila JV, Strandberg TE, Tilvis RS Multicomponent geriatric intervention for elderly inpatients with delirium: a randomized, controlled trial. J Gerontol A Biol Sci Med Sci 2006, 61:176-181.
29. Flaherty JH, Little MO Matching the environment to patients with delirium: lessons learned from the delirium room, a restraint-free environment for older hospitalized adults with delirium. J Am Geriatr Soc 2011, 59(suppl 2):295-300.
30. Rizzo JA, Bogardus ST, Leo-Summers L, Williams CS, Acampora D, Inouye SK Multicomponent targeted intervention to prevent delirium in hospitalized older patients: what is the economic value?. Med Care 2001, 39:740-752.
31. Leslie DL, Inouye SK The importance of delirium: economic and societal costs. J Am Geriatr Soc 2011, 59:S241-S243.
32. National partnership to improve dementia care in nursing homes Centers for Medicare & Medicaid Services, (accessed June 9, 2014). http://www.cms.gov/Outreach-and-Education/Outreach/NPC/National-Provider-Calls-and-Events-Items/2013-11-25-NPC-Dementia-Care.html.
33. Official hospital compare data Centers for Medicare & Medicaid Services, (accessed June 9, 2014). http://www.cms.gov/Outreach-and-Education/Outreach/NPC/National-Provider-Calls-and-Events-Items/2014-05-20-Dementia-Care.html.